Medicovih

¿Con qué frecuencia deben hacerse pruebas de ITS a los usuarios de PrEP?

How often should PrEP users be tested for STIs? Dutch researchers have found that 79% of s*xually transmitted infections (STIs) diagnosed during PrEP users’ routine three-monthly checkups were asymptomatic. They also found that over half (52%) of these infections would have remained undiagnosed, and untreated, for an additional three months if ...

Los datos australianos a nivel nacional muestran que la PrEP tiene un efecto mayormente neutral en la incidencia de ITS.

Nationwide Australian data shows PrEP has largely neutral effect on STI incidence The largest study ever of the incidence of bacterial s*xually transmitted infections (STIs) among gay and bis*xual men who start HIV pre-exposure prophylaxis (PrEP) has found slight but statistically significant declines in chlamydia and gonorrhoea cases in the first couple of years after they start...

Un estudio del 'mundo real' encuentra que la PrEP puede estar deteniendo el 60 % de las infecciones por VIH en hombres franceses con alto riesgo de contraer el VIH.

'Real-world' study finds PrEP may be stopping 60% of HIV infections in French men at high risk of HIV A study in France that matched new HIV diagnoses in adult men who had been taking PrEP with diagnoses in men at similar risk who had not been taking it, has found that the overall effectiveness of PrEP in stopping infection in this high-risk population was 60%. This 60% effectiveness figure included...

Eficacia de la vacuna NVX-CoV2373 COVID-19 en pacientes con y sin VIH.

Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Patients With vs Without HIV Researchers assessed humoral responses to COVID-19 vaccination with NVX-CoV2373 among patients with vs without HIV infection on the basis of prior COVID-19 exposure.

Aumento sustancial de peso a medida que se implementa dolutegravir en África.

Substantial weight gain as dolutegravir is rolled out in Africa A study analysing data from four African countries found that people living with HIV who switched to a dolutegravir-based antiretroviral regimen had a four-fold increase in average weight gain, compared to the year before the switch.

Un metanálisis revela la alta prevalencia mundial de la violencia de pareja entre las personas que viven con el VIH.

Meta-analysis reveals the high global prevalence of intimate partner violence among people living with HIV Four in ten people living with HIV have ever experienced intimate partner violence, with two in ten people experiencing it in the previous year. This is according to the results of a systematic review and meta-analysis published in Trauma, Violence, & Abuse. Emotional abuse was the most prevalen...

Fluconazol versus otros antimicóticos para la candidiasis esofágica en pacientes con VIH.

Fluconazole vs Other Antifungals for Esophageal Candidiasis in Patients With HIV In this meta-analysis, researchers assessed the safety and efficacy of fluconazole compared with alternative antifungal agents for the treatment of esophageal candidiasis.

Resultados, seguridad de la bedaquilina basada en el peso en niños con tuberculosis resistente a múltiples fármacos.

Outcomes, Safety of Weight-Based Bedaquiline in Children With Multidrug-Resistant Tuberculosis Researchers assessed the pharmacokinetic profile and safety of weight-based bedaquiline among children with multidrug-resistant tuberculosis.

Injectable Cabotegravir: Effective, May Overcome Challenges of Daily HIV Pre-Exposure Prophylaxis for Women

Injectable Cabotegravir: Effective, May Overcome Challenges of Daily HIV Pre-Exposure Prophylaxis for Women Researchers compared the safety and efficacy of injectable cabotegravir vs oral tenofovir diphosphate plus emtricitabine for the prevention of HIV infection among women.

Resultados perinatales similares entre diferentes regímenes antirretrovirales basados en inhibidores de la proteasa.

Perinatal Outcomes Similar Between Different Protease Inhibitor-Based Antiretroviral Regimens Investigators assessed whether treatment with protease inhibitor-based antiretroviral therapy during pregnancy increases the risk for poor perinatal outcomes among women with HIV infection.

Obtenga su vacuna COVID de refuerzo de primavera, la Asociación Británica del VIH aconseja a todas las personas con VIH.

Get your spring booster COVID shot, British HIV Association advises everyone with HIV The British HIV Association (BHIVA) recently updated its guidance on COVID vaccinations for people with HIV to align with the recommendation by the UK's Joint Committee on Vaccination and Immunisation (JCVI) that people aged 12 years and over who are immunosuppressed, including all people with....

Los expertos recomiendan la quinta vacuna contra el COVID-19 para personas inmunocomprometidas.

Experts Recommend Fifth COVID-19 Vaccination for Immunocompromised People National Comprehensive Cancer Network encourages second mRNA booster shot and offers COVID PrEP advice for people with cancer.

The COVID-19 pandemic disrupted HIV prevention and care in Barcelona, but new cases and viral loads didn’t increase.

The COVID-19 pandemic disrupted HIV prevention and care in Barcelona, but new cases and viral loads didn’t increase In-person healthcare visits related to HIV prevention and care decreased in number at the largest HIV care centre in Spain as a result of lockdowns during the COVID-19 pandemic. While chlamydia and gonorrhoea cases surged in 2020 compared to 2019, new HIV cases decreased by 28%. But the new HIV case...

Índice de masa corporal bajo al inicio del tratamiento y resultados del tratamiento de la tuberculosis resistente a la rifampicina: metanálisis de datos de un participante individual.

Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis AbstractBackground. The impact of low body-mass-index at treatment initiation on rifampicin-resistant tuberculosis treatment outcomes is uncertain. We evaluated

Computerized Cognitive Training May Help HIV-Associated Neurocognitive Disorder.

Computerized Cognitive Training May Help HIV-Associated Neurocognitive Disorder Researchers assessed whether computerized cognitive training programs were associated with improvements in overall cognitive and daily function in patients with HIV infection.

Cuatro de cada diez beneficiarios de la PrEP dejan de tomarla en un plazo de seis meses, según revela un metanálisis mundial.

Four in ten PrEP recipients stop taking it within six months, global meta-analysis reveals A meta-analysis of 59 studies of PrEP from all continents has found that 41% of people who started taking PrEP had discontinued it within six months. Discontinuation rates were much higher in studies for all groups other than gay and bis*xual men and trans women, including female s*x workers, people...

Anuncio del tema del Día Nacional de la Prueba del VIH 2022.

2022 National HIV Testing Day Theme Announcement Dear National HIV Testing Day Partners,On June 27th each year, we observe National HIV Testing Day (NHTD), a day to emphasize and encourage HIV testing. This year, we observe NHTD as COVID-19 and HIV epidemics continue to affect our communities, the nation, public health departments, and healthcare....

Should People With HIV Be Prioritized for Lung Cancer Screening?

Should People With HIV Be Prioritized for Lung Cancer Screening? A small Spanish study suggests that screening people living with HIV for lung cancer results in a high rate of diagnosis.

La profilaxis previa a la exposición al VIH funciona, pero necesita pruebas periódicas.

HIV pre-exposure prophylaxis works but needs regular testing Pre-exposure prophylaxis for HIV as proven to work and is part in many comprehensive prevention programmes. But it requires consistent testing during the use of PrEP argue two studies from Germany and the Netherlands.

CoronaVac shows weaker response in people with HIV.

CoronaVac shows weaker response in people with HIV The Chinese CoronaVac vaccine against SARS-CoV-2 produces strong antibody responses in the majority of people with HIV but these responses are weaker than those in people without HIV, Brazilian researchers report in the journal Lancet HIV. People with CD4 counts below 500 were less likely to show ne...

Expertos de los NIH analizan el control de la COVID-19 en un comentario sobre la inmunidad colectiva

NIH Experts Discuss Controlling COVID-19 in Commentary on Herd Immunity The benefits of achieving herd immunity thresholds have been less successful with respiratory viruses that continually mutate.

Cómo una intervención nacional en Botswana mejoró el inicio del TAR en el mismo día para personas recién diagnosticadas con VIH.

How a national intervention in Botswana improved same-day ART initiation for people newly diagnosed with HIV Fifty-nine percent of adults started ART on the same day as HIV diagnosis, and 78% within seven days following a national intervention to improve rapid ART initiation in Botswana, researchers from the Botswana-University of Maryland School of Medicine reported in the journal AIDS. Strategies deploye...

Cabenuva inyectable ahora se puede iniciar sin introducción oral.

Injectable Cabenuva Can Now Be Started Without Oral Lead-In People can now start Cabenuva injections directly without first taking cabotegravir and rilpivirine pills for a month.

No se han observado infecciones por el VIH en mujeres que usan la PrEP inyectable.

No breakthrough HIV infections seen in women using injectable PrEP A detailed analysis of HIV infections seen in HPTN 084, the study comparing the effectiveness of injectable versus oral HIV pre-exposure prophylaxis (PrEP) in cisgender women, has been published in the Journal of Infectious Diseases. Headline findings were reported in November 2020 when the stu...

¿Es la prueba casera del VPH el futuro para las personas con VIH?

Is Home HPV Testing the Future for People With HIV? A pilot program is assessing whether self-testing for the cancer-causing virus can reach women who otherwise might not get screened.

Una dosis de TAF cada tres días introduce más fármaco en las células que una dosis diaria de TDF.

One dose of TAF every three days gets more drug into cells than a daily dose of TDF Two studies that compared intracellular levels of the drugs used in PrEP found that levels of tenofovir in cells were seven times higher when the newer version of the tenofovir prodrug, tenofovir alafenamide (TAF), was used, than when the older version, tenofovir disoproxil fumarate (TDF), was used.

Tratamiento de ciclo ultracorto para la hepatitis C: alta tasa de fracaso, pero no compromete el tratamiento de segunda línea.

Ultra-short course treatment for hepatitis C: high failure rate but does not compromise second-line treatment Ultra-short treatment courses tailored to a person's pre-treatment viral load deliver lower cure rates than 8-week treatment courses, but failure of ultra-short treatment does not prevent subsequent cure of hepatitis C with a second course of treatment, the STOPHCV1 study has found.

Es más probable que dolutegravir suprima cargas virales muy altas que otros medicamentos de primera línea recomendados.

Dolutegravir more likely to suppress very high viral loads than other recommended first-line drugs People with very high pre-treatment viral loads who took dolutegravir were significantly less likely to have experienced treatment failure nine months after starting treatment compared to people taking other drugs recommended for first-line treatment, a review of more than 2000 people in the United....

Reducción de daños para fumadores que viven con el VIH.

Harm reduction for smokers living with HIV To***co use is now a leading cause of death in people living with HIV in the USA. Increasing cessation rates in this group is a public health priority, yet the results of clinical trials aimed at optimising to***co treatment strategies have been largely disappointing. Combinations of behavioural and...

El cambio a un inhibidor de la integrasa más TAF está asociado con el aumento de peso.

Switching to an Integrase Inhibitor Plus TAF Is Associated With Weight Gain People who switched to such a regimen gained up to 10 pounds in nine months.